Modulari-T (Biosciences)

Sophisticated Receptors For Next-Generation Cell Therapies.

Our modular receptors unlock a new era of safer, cost-effective, and potent treatments for cancer and autoimmune disease.

Despite enormous potential, CAR-T therapy remains limited by its high toxicity and poor therapeutic persistence, especially in the context of solid tumors.

More persistent immune response prevents disease relapse

Complex and logic gated signalling: Modular receptors can be customized and optimized for specific applications

Compatible across immune cells: Functionality tested in T cells, NK cells, monocytes, macrophages, dendritic cells

Compatible with iPSC/ stem cells:MARC expressing stem cells/iPSCs can recreate the entire immune system 

Scalable and cost-effective

Etienne Gagnon

Etienne Gagnon

  • Co-founder & CSO
Delphine Guipouy, PhD

Delphine Guipouy, PhD

  • Principal Scientist
David  Cotnoir-White

David Cotnoir-White

  • Co-founder & CEO
Stephanie  Mok

Stephanie Mok

  • Co-founder & COO